Have your own idea? Try our Stock Screener
German (DAX) Pharma Industry Analysis
UpdatedJul 02, 2026
DataAggregated Company Financials
Companies9
- 7D10.8%
- 3M27.0%
- 1Y47.4%
- YTD23.0%
In the last week, the Pharma industry is up 11%, with Bayer up 24%. This takes the industry's 12 month performance to a gain of 47%. Looking forward, earnings are forecast to grow by 24% annually.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 02 Jul 2026 | €114.0b | €67.4b | €482.6m | 24.8x | 236.3x | 1.7x |
| Sat, 30 May 2026 | €96.0b | €67.4b | €482.2m | 22.5x | 199x | 1.4x |
| Mon, 27 Apr 2026 | €89.4b | €67.9b | -€883,904,671.20 | 17.9x | -101.1x | 1.3x |
| Wed, 25 Mar 2026 | €84.9b | €67.9b | -€900,280,523.22 | 18.3x | -94.3x | 1.3x |
| Fri, 20 Feb 2026 | €103.1b | €68.3b | €2.9b | 18.2x | 36x | 1.5x |
| Sun, 18 Jan 2026 | €100.1b | €68.3b | €2.9b | 18.2x | 34.9x | 1.5x |
| Tue, 16 Dec 2025 | €89.6b | €68.3b | €2.9b | 17.3x | 31.3x | 1.3x |
| Thu, 13 Nov 2025 | €81.9b | €68.8b | -€439,219,947.99 | 18.5x | -186.5x | 1.2x |
| Sat, 11 Oct 2025 | €81.0b | €68.8b | -€438,973,610.54 | 19x | -184.4x | 1.2x |
| Mon, 08 Sep 2025 | €78.4b | €68.9b | -€406,177,264.31 | 17.1x | -192.9x | 1.1x |
| Wed, 06 Aug 2025 | €77.3b | €69.4b | -€289,963,121.85 | 17.1x | -266.4x | 1.1x |
| Fri, 04 Jul 2025 | €76.2b | €69.4b | -€283,071,598.00 | 17.7x | -269.3x | 1.1x |
| Sun, 01 Jun 2025 | €77.0b | €69.4b | -€209,654,848.00 | 18x | -367.4x | 1.1x |
| Tue, 29 Apr 2025 | €78.6b | €69.3b | €463.1m | 18.7x | 169.7x | 1.1x |
| Thu, 27 Mar 2025 | €80.2b | €69.2b | €436.0m | 19.9x | 183.9x | 1.2x |
| Sat, 22 Feb 2025 | €83.3b | €69.2b | €2.0b | 21.9x | 41.1x | 1.2x |
| Mon, 20 Jan 2025 | €85.0b | €69.2b | €2.0b | 22.8x | 42.3x | 1.2x |
| Wed, 18 Dec 2024 | €82.5b | €69.2b | €2.0b | 22.6x | 41.1x | 1.2x |
| Fri, 15 Nov 2024 | €86.2b | €69.1b | €1.9b | 22x | 44.3x | 1.2x |
| Sun, 13 Oct 2024 | €96.3b | €69.4b | €1.6b | 20.7x | 61.7x | 1.4x |
| Tue, 10 Sep 2024 | €104.3b | €69.3b | €1.5b | 24.6x | 70.8x | 1.5x |
| Thu, 08 Aug 2024 | €99.5b | €69.3b | €1.5b | 30.2x | 68.4x | 1.4x |
| Sat, 06 Jul 2024 | €94.6b | €69.2b | -€303,627,757.00 | 29.8x | -311.7x | 1.4x |
| Mon, 03 Jun 2024 | €102.7b | €69.2b | -€308,637,180.00 | 20.7x | -332.9x | 1.5x |
| Wed, 01 May 2024 | €93.9b | €70.0b | -€32,802,180.00 | 20x | -2863.3x | 1.3x |
| Fri, 29 Mar 2024 | €101.4b | €70.0b | -€34,208,180.00 | 21.4x | -2964.4x | 1.4x |
| Sun, 25 Feb 2024 | €100.1b | €70.6b | -€650,504,143.00 | 19.2x | -153.9x | 1.4x |
| Tue, 23 Jan 2024 | €99.2b | €70.6b | -€650,504,143.00 | 20.4x | -152.5x | 1.4x |
| Thu, 21 Dec 2023 | €96.3b | €70.6b | -€650,606,256.00 | 19.4x | -148x | 1.4x |
| Sat, 18 Nov 2023 | €111.5b | €70.6b | -€653,407,256.00 | 18.9x | -170.7x | 1.6x |
| Mon, 16 Oct 2023 | €110.8b | €72.1b | €4.7b | 19x | 23.7x | 1.5x |
| Wed, 13 Sep 2023 | €122.3b | €72.1b | €4.7b | 21.7x | 26.3x | 1.7x |
| Fri, 11 Aug 2023 | €126.4b | €72.1b | €4.7b | 21.2x | 26.9x | 1.8x |
| Sun, 09 Jul 2023 | €114.6b | €74.1b | €6.5b | 17.9x | 17.8x | 1.5x |
Price to Earnings Ratio
17.8x
Current Industry PE
- Investors are optimistic on the German Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 236x which is higher than its 3-year average PE of 133x.
- The 3-year average PS ratio of 1.3x is lower than the industry's current PS ratio of 1.7x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 58% per year over the last three years,
- Revenues have also declined 3.1% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | 0.57% | |
| Healthcare | 5.87% | |
| Pharma | 10.80% | |
| Pharma | 10.80% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BAYN Bayer | €49.00 | 23.8% +€9.2b | 85.9% | PS1.1x | |
| MRK Merck KGaA | €144.50 | 3.1% +€1.9b | 28.2% | PE24.8x | |
| HIGH Cantourage Group | €6.20 | 2.6% +€2.0m | 19.2% | PE611.4x | |
| SBX SynBiotic | €1.20 | 6.0% +€463.8k | -60.6% | n/a | |
| 93M1 MPH Health Care | €28.60 | 0.4% +€428.1k | 55.9% | PS2.4x |